Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer

被引：18
作者：
Tomasini, Pascale [1 ,2 ]
Greillier, Laurent [1 ,2 ]
Boyer, Arnaud [1 ,2 ]
Jeanson, Arnaud [1 ,2 ]
Barlesi, Fabrice [1 ,2 ]
机构：
[1] Aix Marseille Univ, Multidisciplinary Oncol & Therapeut Innovat Dept, AP HM, Marseille, France
[2] Aix Marseille Univ UM105, Inserm UMR1068, CNRS UMR7258, Predict Oncol Lab,Ctr Rech Cancerol Marseille, Marseille, France
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷
关键词：
TREMELIMUMAB COMBINATION THERAPY; PLATINUM-BASED CHEMOTHERAPY; 1ST-LINE TREATMENT; PLUS TREMELIMUMAB; PATIENTS PTS; MEDI4736; PHASE-3; NSCLC; RADIOTHERAPY; MULTICENTER;
D O I：
10.21037/jtd.2018.04.61
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：S1032 / S1036
页数：5
相关论文
共 17 条
  • [1] Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
    Antonia, S. J.
    Villegas, A.
    Daniel, D.
    Vicente, D.
    Murakami, S.
    Hui, R.
    Yokoi, T.
    Chiappori, A.
    Lee, K. H.
    de Wit, M.
    Cho, B. C.
    Bourhaba, M.
    Quantin, X.
    Tokito, T.
    Mekhail, T.
    Planchard, D.
    Kim, Y. -C.
    Karapetis, C. S.
    Hiret, S.
    Ostoros, G.
    Kubota, K.
    Gray, J. E.
    Paz-Ares, L.
    de Castro Carpeno, J.
    Wadsworth, C.
    Melillo, G.
    Jiang, H.
    Huang, Y.
    Dennis, P. A.
    Ozguroglu, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20) : 1919 - 1929
  • [2] Safety and antitumour activity of durvalumab plus tremelimumab in non-small-cell lung cancer: a multicentre, phase 1b study
    Antonia, Scott
    Goldberg, Sarah B.
    Balmanoukian, Ani
    Chaft, Jamie E.
    Sanborn, Rachel E.
    Gupta, Ashok
    Narwal, Rajesh
    Steele, Keith
    Gu, Yu
    Karakunnel, Joyson J.
    Rizvi, Naiyer A.
    [J]. LANCET ONCOLOGY, 2016, 17 (03) : 299 - 308
  • [3] Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer
    Auperin, Anne
    Le Pechoux, Cecile
    Rolland, Estelle
    Curran, Walter J.
    Furuse, Kiyoyuki
    Fournel, Pierre
    Belderbos, Jose
    Clamon, Gerald
    Ulutin, Hakki Cuneyt
    Paulus, Rebecca
    Yamanaka, Takeharu
    Bozonnat, Marie-Cecile
    Uitterhoeve, Apollonia
    Wang, Xiaofei
    Stewart, Lesley
    Arriagada, Rodrigo
    Burdett, Sarah
    Pignon, Jean-Pierre
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) : 2181 - 2190
  • [4] Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
    Bradley, Jeffrey D.
    Paulus, Rebecca
    Komaki, Ritsuko
    Masters, Gregory
    Blumenschein, George
    Schild, Steven
    Bogart, Jeffrey
    Hu, Chen
    Forster, Kenneth
    Magliocco, Anthony
    Kavadi, Vivek
    Garces, Yolanda I.
    Narayan, Samir
    Iyengar, Puneeth
    Robinson, Cliff
    Wynn, Raymond B.
    Koprowski, Christopher
    Meng, Joanne
    Beitler, Jonathan
    Gaur, Rakesh
    Curran, Walter, Jr.
    Choy, Hak
    [J]. LANCET ONCOLOGY, 2015, 16 (02) : 187 - 199
  • [5] Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
    Butts, Charles
    Socinski, Mark A.
    Mitchell, Paul L.
    Thatcher, Nick
    Havel, Libor
    Krzakowski, Maciej
    Nawrocki, Sergiusz
    Ciuleanu, Tudor-Eliade
    Bosquee, Lionel
    Manuel Trigo, Jose
    Spira, Alexander
    Tremblay, Lise
    Nyman, Jan
    Ramlau, Rodryg
    Wickart-Johansson, Gun
    Ellis, Peter
    Gladkov, Oleg
    Pereira, Jose Rodrigues
    Eberhardt, Wilfried Ernst Erich
    Helwig, Christoph
    Schroeder, Andreas
    Shepherd, Frances A.
    [J]. LANCET ONCOLOGY, 2014, 15 (01) : 59 - 68
  • [6] Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice
    Deng, Liufu
    Liang, Hua
    Burnette, Byron
    Beckett, Michael
    Darga, Thomas
    Weichselbaum, Ralph R.
    Fu, Yang-Xin
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (02) : 687 - 695
  • [7] Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
    Dewan, M. Zahidunnabi
    Galloway, Ashley E.
    Kawashima, Noriko
    Dewyngaert, J. Keith
    Babb, James S.
    Formenti, Silvia C.
    Demaria, Sandra
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (17) : 5379 - 5388
  • [8] Durvalumab in ≥3rd-Line Locally Advanced or Metastatic, EGFR/ALK Wild-Type NSCLC: Results from the Phase 2 ATLANTIC Study
    Garassino, Marina
    Vansteenkiste, Johan
    Kim, Joo-Hang
    Lena, Herve
    Mazieres, Julien
    Powderly, John
    Dennis, Phillip
    Huang, Yifan
    Wadsworth, Catherine
    Rizvi, Naiyer
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S10 - S11
  • [9] Hellmann MD, 2017, LANCET ONCOL, V18, P31, DOI [10.1016/s1470-2045(16)30624-6, 10.1016/S1470-2045(16)30624-6]
  • [10] PD-L1 Blockade for Cancer Treatment: MEDI4736
    Ibrahim, Ramy
    Stewart, Ross
    Shalabi, Aiman
    [J]. SEMINARS IN ONCOLOGY, 2015, 42 (03) : 474 - 483
12